Neuropathic Pain: development and validation of a clinical prediction rule

Neuropathic Pain: development and validation of a clinical prediction rule - Prediction of Neuropathic Pain

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON41339

Enrollment

480

Registered

2010-01-07

Start date

2010-02-26

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

laesie of ziekte van het somatosensorische systeem, aandoening van het centrale of perifere zenuwstelsel 'nerve pain' 'neuropathic pain'

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: A for neuropathic pain plausible anatomical distribution of the pain and/or a clinical record that indicates a lesion or disease of the central or peripheral nervous system.;At least 2 positive signs from a bedsite-QST-protocol;Able to speak Dutch adequately;Signed informed consent

Exclusion criteria

Exclusion criteria: terminally ill patients patients who don't speak Dutch adequately no informed consent

Design outcomes

Primary

Measure	Time frame
Primary study parameters: severeness of pain, measured using the Numeric Rating Scale (NRS) severeness of neuropathic pain, measured using the Neuropathic Pain Scale (NPS)	—

Secondary

Measure	Time frame
Secondary study parameters: Signs of NP (hyper/hypoalgesia, deep pressure pain, hyper/hypoesthesia, allodynia, vibration sense, joint position sense, two point discrimination), measured using bedside-QST Signs of sensory dysregulation, measured using diffuse noxious inhibitory control (DNIC) and summation Patient Global Impression of Change (PGIC) Self Efficacy Scale Disability Rating Index (DRI) Impact on Participation and Autonomy (IPA) Quality of Life, measured using SF-36 and Euroqol Physical co-morbidity, measured using Cumulative Illness Rating Scale-Geriatric (CIRS-G) Depression / Trait anxiety, measured using Hospital Anxiety Depression Scales (HADS) Pain coping, measured using Pain Coping Inventory (PCI) Catastrophizing, measured using Pain Catastrophizing Scale (PCS) Fear of movement, measured using Tampa Scale for Kinesiophobia (TSK) Age Gender Education Treatment Medical consumption Work status Social support	—

Measure

Time frame

Secondary study parameters: Signs of NP (hyper/hypoalgesia, deep pressure pain, hyper/hypoesthesia, allodynia, vibration sense, joint position sense, two point discrimination), measured using bedside-QST Signs of sensory dysregulation, measured using diffuse noxious inhibitory control (DNIC) and summation Patient Global Impression of Change (PGIC) Self Efficacy Scale Disability Rating Index (DRI) Impact on Participation and Autonomy (IPA) Quality of Life, measured using SF-36 and Euroqol Physical co-morbidity, measured using Cumulative Illness Rating Scale-Geriatric (CIRS-G) Depression / Trait anxiety, measured using Hospital Anxiety Depression Scales (HADS) Pain coping, measured using Pain Coping Inventory (PCI) Catastrophizing, measured using Pain Catastrophizing Scale (PCS) Fear of movement, measured using Tampa Scale for Kinesiophobia (TSK) Age Gender Education Treatment Medical consumption Work status Social support

—

Countries

Netherlands

Outcome results